HEPATOBILIARY SCANNING IN PATIENTS WITH CYSTIC-FIBROSIS AND LIVER-DISEASE BEFORE AND AFTER URSODEOXYCHOLIC ACID (UDCA) THERAPY

被引:0
|
作者
COLOMBO, C
CASTELLANI, MR
SEREGNI, E
APOSTOLO, MG
FORMAN, S
GIUNTA, A
机构
[1] UNIV MILAN,DEPT PEDIAT,I-20122 MILAN,ITALY
[2] IST NAZL STUDIO & CURA TUMORI,DIV NUCL MED,I-20133 MILAN,ITALY
关键词
D O I
10.1203/00006450-199005000-00064
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:536 / 536
页数:1
相关论文
共 50 条
  • [1] EFFECTS OF URSODEOXYCHOLIC ACID THERAPY FOR LIVER-DISEASE ASSOCIATED WITH CYSTIC-FIBROSIS
    COLOMBO, C
    SETCHELL, KDR
    PODDA, M
    CROSIGNANI, A
    RODA, A
    CURCIO, L
    RONCHI, M
    GIUNTA, A
    JOURNAL OF PEDIATRICS, 1990, 117 (03): : 482 - 489
  • [2] SCINTIGRAPHIC DOCUMENTATION OF AN IMPROVEMENT IN HEPATOBILIARY EXCRETORY FUNCTION AFTER TREATMENT WITH URSODEOXYCHOLIC ACID IN PATIENTS WITH CYSTIC-FIBROSIS AND ASSOCIATED LIVER-DISEASE
    COLOMBO, C
    CASTELLANI, MR
    BALISTRERI, WF
    SEREGNI, E
    ASSAISSO, ML
    GIUNTA, A
    HEPATOLOGY, 1992, 15 (04) : 677 - 684
  • [3] THE EFFECT OF URSODEOXYCHOLIC ACID (UDCA) ON LIVER-FUNCTION AND BILE-ACID METABOLISM IN PATIENTS WITH CYSTIC-FIBROSIS (CF) AND LIVER-DISEASE
    COLOMBO, C
    GIUNTA, A
    PODDA, M
    CROSIGNANI, A
    ZIMMERNECHEMIAS, L
    SETCHELL, KDR
    HEPATOLOGY, 1989, 10 (04) : 726 - 726
  • [4] URSODEOXYCHOLIC TREATMENT IN PATIENTS WITH CYSTIC-FIBROSIS AND ASSOCIATED LIVER-DISEASE
    GALABERT, C
    LENGRAND, D
    MONTET, JC
    DIMIER, JL
    CHAZALETTE, JP
    PATHOLOGIE BIOLOGIE, 1991, 39 (06): : 625 - 628
  • [5] COMPREHENSIVE STUDY OF THE BILIARY BILE-ACID COMPOSITION OF PATIENTS WITH CYSTIC-FIBROSIS AND ASSOCIATED LIVER-DISEASE BEFORE AND AFTER UDCA ADMINISTRATION
    NAKAGAWA, M
    COLOMBO, C
    SETCHELL, KDR
    HEPATOLOGY, 1990, 12 (02) : 322 - 334
  • [6] HEPATOBILIARY SCINTIGRAPHY IN CHILDREN WITH CYSTIC-FIBROSIS AND LIVER-DISEASE
    DOGAN, AS
    CONWAY, JJ
    LLOYDSTILL, JD
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (03) : 432 - 435
  • [7] URSODEOXYCHOLIC ACID THERAPY IN CYSTIC-FIBROSIS ASSOCIATED LIVER-DISEASE - A DOSE-RESPONSE STUDY
    COLOMBO, C
    CROSIGNANI, A
    ASSAISSO, M
    BATTEZZATI, PM
    PODDA, M
    GIUNTA, A
    ZIMMERNECHEMIAS, L
    SETCHELL, KDR
    HEPATOLOGY, 1992, 16 (04) : 924 - 930
  • [8] QUANTITATIVE HEPATOBILIARY SCINTIGRAPHY IN CHILDREN WITH CYSTIC-FIBROSIS AND LIVER-DISEASE
    DOGAN, AS
    LLOYDSTILL, JD
    CONWAY, JJ
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P226 - P226
  • [9] URSODEOXYCHOLIC ACID (UDCA) THERAPY IN PEDIATRIC HEPATOBILIARY DISEASE
    BALISTRERI, WF
    HEUBI, JE
    WHITINGTON, P
    PERRAULT, J
    BANCROFT, J
    SETCHELL, KDR
    HEPATOLOGY, 1989, 10 (04) : 602 - 602
  • [10] MARKEDLY DECREASED BILIARY URSODEOXYCHOLIC ACID (UDCA) ENRICHMENT WITH HIGH-DOSE UDCA IN CYSTIC-FIBROSIS (CF) ASSOCIATED LIVER-DISEASE - OPTIMIZATION OF THE THERAPEUTIC DOSE
    SETCHELL, KDR
    OCONNELL, NC
    BERN, E
    RODRIGUES, C
    FITZSIMMONS, S
    TERRIN, M
    GRAND, R
    HEPATOLOGY, 1994, 20 (04) : A262 - A262